1. Home
  2. RGNX vs FFIC Comparison

RGNX vs FFIC Comparison

Compare RGNX & FFIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • FFIC
  • Stock Information
  • Founded
  • RGNX 2008
  • FFIC 1929
  • Country
  • RGNX United States
  • FFIC United States
  • Employees
  • RGNX N/A
  • FFIC N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • FFIC Major Banks
  • Sector
  • RGNX Health Care
  • FFIC Finance
  • Exchange
  • RGNX Nasdaq
  • FFIC Nasdaq
  • Market Cap
  • RGNX 459.1M
  • FFIC 454.6M
  • IPO Year
  • RGNX 2015
  • FFIC 1995
  • Fundamental
  • Price
  • RGNX $7.62
  • FFIC $14.26
  • Analyst Decision
  • RGNX Strong Buy
  • FFIC Hold
  • Analyst Count
  • RGNX 12
  • FFIC 4
  • Target Price
  • RGNX $36.00
  • FFIC $15.50
  • AVG Volume (30 Days)
  • RGNX 1.7M
  • FFIC 453.4K
  • Earning Date
  • RGNX 11-06-2024
  • FFIC 01-23-2025
  • Dividend Yield
  • RGNX N/A
  • FFIC 6.17%
  • EPS Growth
  • RGNX N/A
  • FFIC N/A
  • EPS
  • RGNX N/A
  • FFIC 0.87
  • Revenue
  • RGNX $84,327,000.00
  • FFIC $193,714,000.00
  • Revenue This Year
  • RGNX $2.34
  • FFIC N/A
  • Revenue Next Year
  • RGNX $243.67
  • FFIC $14.16
  • P/E Ratio
  • RGNX N/A
  • FFIC $16.39
  • Revenue Growth
  • RGNX N/A
  • FFIC 4.54
  • 52 Week Low
  • RGNX $7.21
  • FFIC $10.74
  • 52 Week High
  • RGNX $28.80
  • FFIC $18.59
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 36.08
  • FFIC 27.93
  • Support Level
  • RGNX $8.06
  • FFIC $13.97
  • Resistance Level
  • RGNX $10.52
  • FFIC $15.45
  • Average True Range (ATR)
  • RGNX 0.76
  • FFIC 0.59
  • MACD
  • RGNX -0.19
  • FFIC -0.42
  • Stochastic Oscillator
  • RGNX 12.39
  • FFIC 7.30

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About FFIC Flushing Financial Corporation

Flushing Financial Corp operates as a bank holding company, which is engaged in the provision of banking and financial services. It provides Personal, Business, lending, Government banking, and Card services. Its principal business is attracting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, in originations and purchases of multi-family residential properties, commercial business loans, commercial real estate mortgage loans, construction loans, small business administration loans, and other small business loans.

Share on Social Networks: